Kraig Biocraft Laboratories Inc (KBLB)

[WebSlinger]

<< IF the company could not mass produce at all, how would they make the shoot packs? >>

This has already been covered multiple times. Here is a reply from yesterday to this exact question:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=138443978

In short:

- First, KBLB has NOT completed the sample shootpacks yet. They have been trying for a year and a half to create the samples and the jury is still out if they will ever be able to complete them.

- Second, even if they can produce the sample shootpacks in time, that doesn't mean that they can mass produce anything. Just because they can make a few samples, doesn't mean that you can extrapolate that to mass production.

If I can bake a loaf of bread in my oven, does that mean that I can now get a contract with Kroger to sell them a million loaves? The answer is obviously "NO". Making a few samples doesn't mean that you can mass produce.

<< Folks complained that there was no update on the shoot packs. Not only did we get an update, we got the month, even if it comes at the end of March. >>

We have already received a "month" twice before. They were called deadlines. The first deadline was Apr 2017. They missed that one by a longshot. It wasn't even close. The Army was gracious enough to give KBLB another shot and added another 8 months onto the schedule. That extended the deadline to Dec 2017 (and almost doubled the original timeline). You would have thought that would have been PLENTY of time. But no, KBLB managed to miss that deadline as well. At this point, you have to wonder what type of impression KBLB is forming on the Army (when they haven't made either of their deadlines). Now we have a 3rd "time estimate" - Mar 2018. I didn't call it a deadline because we have no idea if the Army has agreed to it. If the Army agreed to it, then there should have been a modification made to the contract and I don't see one yet. I doubt KBLB will be able to make that "time estimate" either, but we will see. Time will tell.